Compare OneSpan Inc (OSPN) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
OneSpan Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? OneSpan Inc trades at $18.13 (market cap $662.97M), while Royalty Pharma plc Class A Ordinary Shares trades at $57.06 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 38.1× OneSpan Inc's market cap, and OneSpan Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| OSPN | RPRX | |
|---|---|---|
Market Cap | $662.97M | $25.27B |
Volume | 616,882 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $18.42 | $63.96 |
52-Week Low | $10.15 | $35.44 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | $632.05M | $32.50B |
Dividend Yield | 2.89% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OneSpan (OSPN) trades at $17.70, down 3.7% in the last session, but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows a bullish technical signal with support at $17 and resistance at $18. Recent Q2 2026 results exceeded expectations with EPS of $0.30 versus $0.231 expected, while the company introduced new authentication technology to drive future growth.
The outlook remains positive given strong analyst support (66.7% buy ratings) and solid financial metrics, though investors should monitor declining cash flow trends and competitive pressures in the cybersecurity sector. The stock presents value opportunity with P/E of 10.16 and ROE of 26.51%, but faces execution risks in maintaining subscription revenue growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
